loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_1997_050___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Albemarle Corporation

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    SERVICES

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Albemarle Corporation Orangeburg US (1)

    filter

    01 Naproxen (1)

    filter

    01 U.S.A (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Albemarle Corporation Orangeburg US

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Naproxen

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 1997-050 - Rev 03
    Withdrawn by Holder
    Chemical
    2008-08-14
    2013-01-14
    731
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 1997-050 - Rev 03 of Albemarle Corporation Orangeburg Us

    Looking for Certificates of Suitability (CEPs) for R1-CEP 1997-050 - Rev 03 of Albemarle Corporation Orangeburg Us 1

    20

    Albemarle Corporation Orangeburg Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their significant offerings is Naproxen, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1997-050 - Rev 03

    This Chemical Type CEP, issued on August 14, 2008, remains in force until January 14, 2013, ensuring its reliability within the pharmaceutical industry.

    Substance Number 731 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY